Chemoinformaics analysis of (5-METHYL-2-PROP-1-EN-2-YLHEX-4-ENYL) ACETATE
Molecular Weight | 196.29 | nRot | 5 |
Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
Exact Molecular Weight | 196.146 | nRing | 0 |
Solubility: LogS | -6.066 | nHRing | 0 |
Solubility: LogP | 6.263 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 34.9799 |
nHD | 0 | BPOL | 22.6681 |
QED | 0.282 |
Synth | 1.955 |
Natural Product Likeliness | 0.416 |
NR-PPAR-gamma | 0.957 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.019 |
Pgp-sub | 0.009 |
HIA | 0.002 |
CACO-2 | -4.718 |
MDCK | 0.0000237 |
BBB | 0.672 |
PPB | 0.972611 |
VDSS | 1.093 |
FU | 0.0240331 |
CYP1A2-inh | 0.836 |
CYP1A2-sub | 0.195 |
CYP2c19-inh | 0.562 |
CYP2c19-sub | 0.104 |
CYP2c9-inh | 0.377 |
CYP2c9-sub | 0.938 |
CYP2d6-inh | 0.069 |
CYP2d6-sub | 0.068 |
CYP3a4-inh | 0.377 |
CYP3a4-sub | 0.09 |
CL | 4.881 |
T12 | 0.229 |
hERG | 0.056 |
Ames | 0.007 |
ROA | 0.034 |
SkinSen | 0.96 |
Carcinogencity | 0.2 |
EI | 0.976 |
Respiratory | 0.61 |
NR-Aromatase | 0.259 |
Antiviral | No |
Prediction | 0.667874 |